Trials Currently Enrolling at Associated Neurologists

Alzheimer’s Disease | Dementia | Epilepsy | Multiple SclerosisNeurogenic Orthostatic Hypotension |

Alzheimer’s Disease

Protocol Title"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to assess the Efficacy, Safety, and Tolerability of AVP786 (deuterated [d6]- dextromethorphan hydrobromide [d6-DM]/ quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer's type"
Trial PhasePhase III
Principal Investigator (PI)Samuel Markind, MD
Protocol Number15-AVP-786-302
ClinicalTrials.gov Identifier:NCT02442778
For further information on this trial from ClinicalTrials.govClick here.
Protocol Title"A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer’s Disease Dementia (The Daybreak Study)"
Trial PhasePhase III
Principal Investigator (PI)Samuel Markind, MD
Protocol NumberI8D-MC-MZET
ClinicalTrials.gov Identifier:NCT02783573
For further information on this trial from ClinicalTrials.govClick here.
Protocol Title"A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer’s Disease (Serene Study)"
Trial PhasePhase II
Principal Investigator (PI)Robert Bonwetsch, MD
Protocol NumberACP-103-032
ClinicalTrials.gov Identifier:NCT02992132
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Dementia

Protocol Title"A double-blind, placebo-controlled, relapse prevention study of Pimavanserin for the treatment of Hallucinations and delusions associated with Dementia- related psychosis"
Trial PhasePhase III
Principal Investigator (PI)Robert Bonwetsch, MD
Protocol NumberACP-103-045
ClinicalTrials.gov Identifier:Not listed at this time
For further information on this trial from ClinicalTrials.govNot available at this time

Return to Top

Epilepsy

Protocol Title"A Double-Blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy"
Trial PhasePhase III
Principal Investigator (PI)Williams Yorns, DO
Protocol NumberSP0982
ClinicalTrials.gov Identifier:NCT02408523
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

Multiple Sclerosis

Protocol Title"A Multicenter, global, observational study to collect information on safety and to document the drug utilization of Tecfidera ™ (Dimethyl Fumarate) when used in routine medical practice in the treatment of MULTIPLE SCLEROSIS (ESTEEM)"
Trial PhasePhase IV
Principal Investigator (PI)David Greco, MD
Protocol Number109MS401
ClinicalTrials.gov Identifier:Click here.

Return to Top

Neurogenic Orthostatic Hypotension

Protocol Title"RESTORE: A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of Droxidopa therapy"
Trial PhasePhase IV
Principal Investigator (PI)Behzad Habibi, MD
Protocol Number16306A
ClinicalTrials.gov Identifier:NCT02586623
For further information on this trial from ClinicalTrials.govClick here.

Return to Top

If you would like to learn more about any of the trials above, please contact our Clinical Research Department at (203) 748-2551, extension 351 for further information.